FDA Approves First Neonatal MRI Device

Share this content:
FDA Approves First Neonatal MRI Device
FDA Approves First Neonatal MRI Device

FRIDAY, July 21, 2017 (HealthDay News) -- The first magnetic resonance imaging (MRI) device designed specifically for neonatal brain and head imaging in intensive care units has been approved by the U.S. Food and Drug Administration.

The Embrace Neonatal MRI System device is designed expressly for taking images of the neonatal head. The system includes a temperature-controlled incubator placed directly into the MRI system, the FDA said.

To avoid putting vulnerable infants at risk, the device was tested using simulated infant brains, the agency added. The device shouldn't be used on infants weighing more than 4.5 kilograms (about 9.9 pounds) or with a head circumference of more than 38 centimeters (about 15 inches).

"Although we can use traditional MRI scanners to image neonates, taking babies outside of the neonatal intensive care unit to MRI suites presents great challenges," Vasum Peiris, M.D., M.P.H., chief medical officer of pediatrics and special populations at the FDA's Center for Devices and Radiological Health, said in a statement. "Having a system in the neonatal intensive care unit enables safer imaging for this vulnerable patient population."

Approval for the device was granted to the Israeli firm Aspect Imaging.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »